Sustainable KLH Technologies for Growing Markets

KLH

"We will aggressively pursue KLH diagnostics for immune competence and companion diagnostics for biomarkers, which have the potential to dramatically impact the commercialization of drug candidates by yielding safer drugs with enhanced therapeutic efficacy and better economic efficiencies."

Herbert S. Chow, Ph.D. - VP, Product Development

KLH

Keyhole limpet hemocyanin (KLH) is a highly potent T-cell dependent immunostimulatory protein and adjuvant. The molecule has an extensive history of safe and effective use in humans for vaccine development and immunological research. As an essential carrier protein for the rapidly developing field of synthetic conjugate vaccines, KLH has proven to be superior at conferring antigenicity to a wide variety of molecular conjugates and has enabled a broad array of new vaccines and active immunotherapies.

The potent immunogenicity and excellent safety record of KLH also makes it an excellent choice for immunological research applications.

Download Presentation
Receive Updates